851 Enhancing cancer immunotherapy with Deinococcus geothermalis in combination with PD-1 inhibitors: a novel strategy for non-small cell lung cancer treatment

Geahča maid

• Circulating low-density neutrophils as biomarkers of resistance to first-line anti-PD-1/PD-L1 immunotherapy in non-small cell lung cancer
  Dahkki: N Castro, et al.
  Almmustuhtton: (2026-05-01)
• Peripheral inflammatory factors as prognostic predictors for first-line PD-1/PD-L1 inhibitors in advanced non-small cell lung cancer
  Dahkki: Chen-xing Jin, et al.
  Almmustuhtton: (2025-04-01)
• T Cell Invigoration is Associated with the Clinical Response to Anti-PD-1-Based Immunotherapy in Non-Small Cell Lung Cancer
  Dahkki: Wu H, et al.
  Almmustuhtton: (2023-10-01)
• Research trends and highlights in PD-1/PD-L1 inhibitor immunotherapy in lung cancer: a bibliometric analysis
  Dahkki: Zheng Gu, et al.
  Almmustuhtton: (2025-03-01)
• Efficacy and safety of PD‐1/PD‐L1 inhibitors in elderly patients with advanced non‐small cell lung cancer
  Dahkki: Li Li, et al.
  Almmustuhtton: (2024-05-01)